Burnham edges closer to Number 10 as Labour rivals step aside
Andy Burnham's path to Downing Street appeared to become clearer on Wednesday after another potential challenger ruled himself out of the Labour leade...
Novartis is closely monitoring the U.S. reciprocal tariff policy, which may impose 25% tariffs on pharmaceuticals. The company plans to expand in Japan with radiopharmaceutical production by 2026 and recently acquired Mariana Oncology for $1B to strengthen its oncology portfolio.
Swiss pharmaceutical giant Novartis is closely monitoring the potential impact of the United States’ proposed reciprocal tariff policy, which is expected to take shape in early April. Chief Executive Vas Narasimhan confirmed in Tokyo that the company is assessing the implications of the policy, particularly on pharmaceutical imports.
U.S. President Donald Trump recently suggested imposing a 25% tariff on imported pharmaceuticals as part of broader trade measures targeting various industries, including semiconductors and automobiles. The move is part of efforts to restructure global trade dynamics and encourage domestic production.
Meanwhile, Novartis is expanding its footprint in Japan, with plans to commence mass production of radiopharmaceuticals in 2026. These precision cancer treatments offer targeted therapy, a growing focus for the pharmaceutical industry.
Last year, Novartis strengthened its oncology portfolio by acquiring U.S.-based Mariana Oncology for $1 billion upfront. This move enhances its offerings, which include prostate cancer treatment Pluvicto and Lutathera for rare gastrointestinal tumors.
As global trade policies evolve, Novartis continues to navigate regulatory challenges while advancing its commitment to innovative cancer therapies.
At least thirteen people have died and sixty-six have been injured following an explosion at Qatar's main liquefied natural gas (LNG) processing hub at Ras Laffan, authorities said on Sunday. Â
Tehran has agreed to let the International Atomic Energy Agency (IAEA) recommence inspections of its nuclear programme, U.S. Vice President JD Vance has said. The U.S. and Iran have settled on a 60-day roadmap aimed at reaching a final deal, according to mediators Qatar and Pakistan. Â
A Ukrainian strike has damaged a school building in a Russian-controlled area of Ukraine’s Zaporizhzhia region, according to local authorities cited by the TASS news agency. No injuries were reported in the incident.
Iran’s parliamentary speaker said on Wednesday regional countries alone should determine the Middle East’s political and security order, rejecting external involvement and calling for expanded intra-regional cooperation.
U.S. President Donald Trump said that Iran had agreed to nuclear inspections into "infinity, despite Tehran's denials, and that unfrozen Iranian assets would be used to buy humanitarian supplies from the United States.
Andy Burnham's path to Downing Street appeared to become clearer on Wednesday after another potential challenger ruled himself out of the Labour leadership race.
France has confirmed its first Ebola case linked to the current outbreak in the Democratic Republic of Congo after a doctor returning from a humanitarian mission tested positive for the virus, the health ministry said on Wednesday (24 June).
Ukraine said its forces had struck key energy installations inside Russia, including a gas processing plant and a helium facility in the Orenburg region, as drone assaults increased across multiple areas.
Critical minerals are becoming a key battleground in the growing economic rivalry between the G7 and China, as governments seek to secure supplies vital to the energy transition and advanced manufacturing.
An unusual weather pattern known as an omega block is at the heart of the extreme heat sweeping across Europe. The phenomenon can trap hot air over the same region for days or even weeks, allowing temperatures to climb to dangerous levels.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment